Navigation Links
Advanced Immune Support Formula Licensed From UC Berkeley Launched

BERKELEY, Calif., Oct. 1 /PRNewswire/ -- Berkeley BioSciences, Inc., co-founded by Dr. Leonard Bjeldanes, Professor and former Chairman of the Department of Nutritional Sciences at UC Berkeley and Dr. Gary Firestone, Director of the National Institutes of Health Cancer Research Program at UC Berkeley, announces the launch of ActivaMune -- an advanced immune support formula exclusively licensed from UC Berkeley. (

ActivaMune is based on a breakthrough discovery by Dr. Bjeldanes and Dr. Firestone regarding the potent immune activating properties of Diindolylmethane (DIM), a naturally occurring compound found in Brassica vegetables (broccoli, cauliflower, cabbage, kale, Brussels sprouts). This compound has been shown to modulate key immune enhancing cytokines in addition to inducing Interferon-Gamma Receptors on diseased cells, selectively marking them for destruction by the immune system with no effect on healthy cells.

DIM, at dietary supplemental dosages, is currently used as a treatment for Recurring Respiratory Papillomatosis tumors (caused by the Human Papillomavirus) and is in Phase III clinical trials for Cervical Dysplasia (also caused by HPV). Until this recent discovery regarding its potent immune modulating properties, the efficacy of this compound against these conditions was not clearly understood. As a result of this discovery, Diindolylmethane is currently under investigation as a natural therapeutic for most viral infections (including HPV, Influenza, Hepatitis & HIV) and antibiotic resistant bacteria. As DIM has both immune modulating properties that fight cancer, as well as direct anti-cancer properties (such as apoptosis promotion) it is also currently in clinical trials sponsored by the National Cancer Institute as a natural therapeutic for various forms of cancer.

Epidemiological studies have indicated that people who regularly consume Brassica vegetables have a significantly lower risk of cancer. Scientists believe that the three principal nutrients in Brassica vegetables responsible for these protective properties are: Diindolylmethane, Sulforaphane and Selenium. ActivaMune is the first dietary supplement in the market to deliver all three of these health promoting nutrients from Brassica vegetables in one capsule. Most Brassica extract pills on the market today do not contain any Diindolylmethane or Sulforaphane in them as the enzyme responsible for their production is destroyed during the manufacturing process. In addition to Brassica phytonutrients, ActivaMune also provides important nutrients from other vegetables as well to promote healthy aging.

Proceeds from ActivaMune sales support research and development of nature-based therapeutics for cancer, AIDS and other diseases.

SOURCE Berkeley BioSciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Achieving Reliable Protein Quantitation Results Using ICAT Reagents, MALDITOF Mass Spectrometry, and Advanced Data Interpretation Tool
2. Precision Testing for the Sciclone Advanced Liquid Handler Z8 Option
3. 384 Well Pipetting Precision and Accuracy Testing Using the Sciclone Advanced Liquid Handler
4. WARF expands license agreement with Advanced Cell Technology
5. Rockwells $1M gift to UWM will support advanced automation research
6. Advanced CIO: Technology execs must trumpet their success
7. FDA approves advanced digital mammography system
8. Tech Digest: Inacom; St. Michaels, St. Clares hospitals; Merge eMed; Advanced Data-Comm; Blue Cross and Blue Shield
9. Wisconsins insurance companies use advanced IT to speed relief
10. $60 Million Available in Advanced Tech Competition
11. Advanced Life Sciences to Hit the Road For $30 Million in Funding
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... Pittcon ... over 2,000 technical presentations offered in symposia, oral sessions, workshops, awards, and posters. ... a wide range of applications such as, but not limited to, biotechnology, biomedical, ...
(Date:11/25/2015)... -- PharmAthene, Inc. (NYSE MKT: PIP) announced  today that its ... (Rights Plan) in an effort to preserve the value ... 382 of the Internal Revenue Code (Code). ... its NOLs could be substantially limited if the Company ... of the Code. In general, an ownership change occurs ...
(Date:11/25/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: AEZ) ... remain fundamentally strong and highlights the following developments: ... DSMB recommendation to continue the ZoptEC Phase 3 ... final interim efficacy and safety data , ... with heavily pretreated castration- and Taxane-resistant prostate cancer ...
(Date:11/24/2015)... , Nov. 24, 2015  Asia-Pacific (APAC) holds ... organisation (CRO) market. The trend of outsourcing to ... margins but higher volume share for the region ... scale, however, margins in the CRO industry will ... Market ( ), finds that the ...
Breaking Biology Technology:
(Date:11/10/2015)... NEW YORK , Nov. 10, 2015 /PRNewswire/ ... refers to behavioral biometrics that helps to identify ... prevent fraud. Signature is considered as the secure ... for the identification of a particular individual because ... offers more accurate results especially when dynamic signature ...
(Date:11/9/2015)... Calif. , Nov. 9, 2015  Synaptics Inc. ... interface solutions, today announced broader entry into the automotive ... solutions that match the pace of consumer electronics human ... biometric sensors are ideal for the automotive industry and ... Europe , ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has been ... provide preclinical development services to the National Cancer Institute ... will provide scientific expertise, modern testing and support facilities, ... preclinical pharmacology and toxicology studies to evaluate potential cancer ... The PREVENT Cancer Drug Development Program is an ...
Breaking Biology News(10 mins):